echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > iPS cells are used for COVID-19 drug screening

    iPS cells are used for COVID-19 drug screening

    • Last Update: 2021-04-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Last year, the world conducted in-depth research on SARS-CoV-2 ( the virus that caused the COVID-19 pandemic).


    COVID-19 infection

    HIV, Ebola virus and now SARS-CoV-2 are all RNA viruses, and these viruses have caused many health disasters.


    management

    Haruhisa Inoue said: "Not only is it necessary to treat current RNA viruses, but also emerging anti-RNA viral therapies.


    prevention

    Sendai virus is an RNA virus commonly used in iPS cell research.


    From the screening of 500 drugs, 5 showed promising prospects worthy of further research, including raloxifene (a drug used to treat breast cancer and osteoporosis ) and pioglitazone (a drug used to treat diabetes medicine).


    From the screening of 500 drugs, 5 showed promising prospects worthy of further research, including raloxifene (a drug used to treat breast cancer and osteoporosis ) and pioglitazone (a drug used to treat diabetes medicine).


    Original source:

    Original source:

    href="" target="_blank" rel="noopener">


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.